Drug profile · INN
ibrexafungerp citrate
BREXAFEMME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ibrexafungerp citrate (BREXAFEMME) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ibrexafungerp citrate
Brand BREXAFEMME
Route ORAL
Formulation TABLET
Frequently asked questions
What is ibrexafungerp citrate?
ibrexafungerp citrate (BREXAFEMME) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ibrexafungerp citrate?
BREXAFEMME is a marketed brand name for ibrexafungerp citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ibrexafungerp citrate?
ibrexafungerp citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.